1. Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, Simonsen L, Viboud C: Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J Glob Health 2019; 9: 020421.
2. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB: Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000; 283: 499- 505.
3. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ, Joint Taskforce of the European Respiratory S, European Society for Clinical M, Infectious D: Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect 2011; 17 Suppl 6: E1-59.
4. Thomas C Cesario: Viruses associated with pneumonia in adults. Clin Infect Dis 2012; 55: 107-13.
5. Jones M, Jefferson T, Doshi P, Del Mar C, Heneghan C, Onakpoya I: Commentary on Cochrane review of neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Clin Microbiol Infect 2015; 21: 217-221.
6. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014: CD008965.
7. Wolkewitz M, Schumacher M: Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data. PLoS One 2016; 11: e0160430.
8. Chatterjee AB: Review: Corticosteroids reduce mechanical ventilation and ARDS in inpatients with community-acquired pneumonia. Ann Intern Med 2015; 163: JC2.
9. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354: 1671-1684.
10. Petrucci N, Iacovelli W: Ventilation with lower tidal volumes versus traditional tidal volumes in adults for acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2003: CD003844.
11. Acute Respiratory Distress Syndrome N, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308.
12. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB: Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020; 323: 1824-1836.
13. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fatkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC, Members A-SG: Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med 2020; 383: 1813-1826.
14. Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen YD, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D'Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK, Investigators BBTT: Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med 2020; 383: 2333-2344.
15. Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, Ellingson MK, Mao T, Oh JE, Israelow B, Takahashi T, Tokuyama M, Lu P, Venkataraman A, Park A, Mohanty S, Wang H, Wyllie AL, Vogels CBF, Earnest R, Lapidus S, Ott IM, Moore AJ, Muenker MC, Fournier JB, Campbell M, Odio CD, Casanovas-Massana A, Yale IT, Herbst R, Shaw AC, Medzhitov R, Schulz WL, Grubaugh ND, Dela Cruz C, Farhadian S, Ko AI, Omer SB, Iwasaki A: Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 2020; 584: 463-469.
16. Takeuchi O, Akira S: Innate immunity to virus infection. Immunol Rev 2009; 227: 75- 86.
17. Stambas J, Lu C, Tripp RA: Innate and adaptive immune responses in respiratory virus infection: implications for the clinic. Expert Rev Respir Med 2020; 14: 1141- 1147.
18. Aoshi T, Koyama S, Kobiyama K, Akira S, Ishii KJ: Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virol 2011; 1: 226-232.
19. Bhoj VG, Chen ZJ: Ubiquitylation in innate and adaptive immunity. Nature 2009; 458: 430-437.
20. Thaiss CA, Zmora N, Levy M, Elinav E: The microbiome and innate immunity. Nature 2016; 535: 65-74.
21. Demaria O, Cornen S, Daeron M, Morel Y, Medzhitov R, Vivier E: Harnessing innate immunity in cancer therapy. Nature 2019; 574: 45-56.
22. Janeway CA, Jr., Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
23. Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1-5.
24. Kollmann TR, Levy O, Montgomery RR, Goriely S: Innate immune function by Toll- like receptors: distinct responses in newborns and the elderly. Immunity 2012; 37: 771- 783.
25. Kawai T, Akira S: Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-650.
26. Blasius AL, Beutler B: Intracellular toll-like receptors. Immunity 2010; 32: 305-315.
27. Loo YM, Gale M, Jr.: Immune signaling by RIG-I-like receptors. Immunity 2011; 34: 680-692.
28. Yoneyama M, Fujita T: Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 2008; 29: 178-181.
29. Kanneganti TD, Lamkanfi M, Nunez G: Intracellular NOD-like receptors in host defense and disease. Immunity 2007; 27: 549-559.
30. Wen H, Miao EA, Ting JP: Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 2013; 39: 432-441.
31. Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL: Host Immune Response to Influenza A Virus Infection. Front Immunol 2018; 9: 320.
32. Arankalle VA, Lole KS, Arya RP, Tripathy AS, Ramdasi AY, Chadha MS, Sangle SA, Kadam DB: Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One 2010; 5.
33. Chen KK, Minakuchi M, Wuputra K, Ku CC, Pan JB, Kuo KK, Lin YC, Saito S, Lin CS, Yokoyama KK: Redox control in the pathophysiology of influenza virus infection. BMC Microbiol 2020; 20: 214.
34. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS, Ghosh S: TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011; 472: 476-480.
35. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A: Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci U S A 2009; 106: 2770-2775.
36. Di Meo S, Reed TT, Venditti P, Victor VM: Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxid Med Cell Longev 2016; 2016: 1245049.
37. Barnes PJ: Oxidative stress-based therapeutics in COPD. Redox Biol 2020; 33: 101544.
38. McGuinness AJ, Sapey E: Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms. J Clin Med 2017; 6.
39. Kirkham PA, Barnes PJ: Oxidative stress in COPD. Chest 2013; 144: 266-273.
40. Nencioni L, Iuvara A, Aquilano K, Ciriolo MR, Cozzolino F, Rotilio G, Garaci E, Palamara AT: Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2. FASEB J 2003; 17: 758-+.
41. Akaike T, Okamoto S, Sawa T, Yoshitake J, Tamura F, Ichimori K, Miyazaki K, Sasamoto K, Maeda H: 8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis. Proc Natl Acad Sci U S A 2003; 100: 685-690.
42. Sgarbanti R, Amatore D, Celestino I, Marcocci ME, Fraternale A, Ciriolo MR, Magnani M, Saladino R, Garaci E, Palamara AT, Nencioni L: Intracellular Redox State as Target for Anti-Influenza Therapy: Are Antioxidants Always Effective? Curr Top Med Chem 2014; 14: 2529-2541.
43. Dickinson DA, Moellering DR, Iles KE, Patel RP, Levonen AL, Wigley A, Darley- Usmar VM, Forman HJ: Cytoprotection against oxidative stress and the regulation of glutathione synthesis. Biol Chem 2003; 384: 527-537.
44. Rahman I, MacNee W: Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000; 16: 534-554.
45. Cai J, Chen Y, Seth S, Furukawa S, Compans RW, Jones DP: Inhibition of influenza infection by glutathione. Free Radic Biol Med 2003; 34: 928-936.
46. Akaike T, Ida T, Wei FY, Nishida M, Kumagai Y, Alam MM, Ihara H, Sawa T, Matsunaga T, Kasamatsu S, Nishimura A, Morita M, Tomizawa K, Nishimura A, Watanabe S, Inaba K, Shima H, Tanuma N, Jung M, Fujii S, Watanabe Y, Ohmuraya M, Nagy P, Feelisch M, Fukuto JM, Motohashi H: Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics. Nat Commun 2017; 8: 1177.
47. Ida T, Sawa T, Ihara H, Tsuchiya Y, Watanabe Y, Kumagai Y, Suematsu M, Motohashi H, Fujii S, Matsunaga T, Yamamoto M, Ono K, Devarie-Baez NO, Xian M, Fukuto JM, Akaike T: Reactive cysteine persulfides and S-polythiolation regulate oxidative stress and redox signaling. Proc Natl Acad Sci U S A 2014; 111: 7606-7611.
48. Numakura T, Sugiura H, Akaike T, Ida T, Fujii S, Koarai A, Yamada M, Onodera K, Hashimoto Y, Tanaka R, Sato K, Shishikura Y, Hirano T, Yanagisawa S, Fujino N, Okazaki T, Tamada T, Hoshikawa Y, Okada Y, Ichinose M: Production of reactive persulfide species in chronic obstructive pulmonary disease. Thorax 2017; 72: 1074- 1083.
49. Hirano T, Kikuchi T, Tode N, Santoso A, Yamada M, Mitsuhashi Y, Komatsu R, Kawabe T, Tanimoto T, Ishii N, Tanaka Y, Nishimura H, Nukiwa T, Watanabe A, Ichinose M: OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia. EMBO Mol Med 2016; 8: 422- 436.
50. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, Si-Tahar M: Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I- dependent antiviral responses in human lung epithelial cells. J Immunol 2007; 178: 3368-3372.
51. To EE, Erlich JR, Liong F, Luong R, Liong S, Esaq F, Oseghale O, Anthony D, McQualter J, Bozinovski S, Vlahos R, O'Leary JJ, Brooks DA, Selemidis S: Mitochondrial Reactive Oxygen Species Contribute to Pathological Inflammation During Influenza A Virus Infection in Mice. Antioxidants & Redox Signaling 2020; 32: 929-942.
52. Lin X, Wang RF, Zou W, Sun X, Liu XK, Zhao LZ, Wang SY, Jin ML: The Influenza Virus H5N1 Infection Can Induce ROS Production for Viral Replication and Host Cell Death in A549 Cells Modulated by Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression. Viruses-Basel 2016; 8.
53. Ye S, Lowther S, Stambas J: Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza A viruses via upregulation of SOCS1 and SOCS3. J Virol 2015; 89: 2672-2683.
54. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YHC, Wang HL, Liu HL, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JSM, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang CY, Binder CJ, Penninger JM: Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008; 133: 235-249.
55. Moriyama M, Nagai M, Maruzuru Y, Koshiba T, Kawaguchi Y, Ichinohe T: Influenza Virus-Induced Oxidized DNA Activates Inflammasomes. Iscience 2020; 23.
56. Hartmann BM, Albrecht RA, Zaslavsky E, Nudelman G, Pincas H, Marjanovic N, Schotsaert M, Martinez-Romero C, Fenutria R, Ingram JP, Ramos I, Fernandez-Sesma A, Balachandran S, Garcia-Sastre A, Sealfon SC: Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death. Nature Communications 2017; 8.
57. Nakamura R, Maeda N, Shibata K, Yamada H, Kase T, Yoshikai Y: Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury. J Virol 2010; 84: 5574-5582.
58. Herold S, Becker C, Ridge KM, Budinger GR: Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 2015; 45: 1463-1478.
59. Reshi ML, Su YC, Hong JR: RNA Viruses: ROS-Mediated Cell Death. Int J Cell Biol 2014; 2014: 467452.
60. Suliman HB, Ryan LK, Bishop L, Folz RJ: Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. American Journal of Physiology-Lung Cellular and Molecular Physiology 2001; 280: L69-L78.
61. Sgarbanti R, Nencioni L, Amatore D, Coluccio P, Fraternale A, Sale P, Mammola CL, Carpino G, Gaudio E, Magnani M, Ciriolo MR, Garaci E, Palamara AT: Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy. Antioxid Redox Signal 2011; 15: 593-606.
62. Geiler J, Michaelis M, Naczk P, Leutz A, Langer K, Doerr HW, Cinatl J, Jr.: N-acetyl- L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem Pharmacol 2010; 79: 413-420.
63. De Flora S, Grassi C, Carati L: Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J 1997; 10: 1535-1541.
64. Ker-Kong Chen , Moeko Minakuchi , Kenly Wuputra , Chia-Chen Ku , Jia-Bin Pan , Kung-Kai Kuo , Ying-Chu Lin , Shigeo Saito , Chang-Shen Lin , Kazunari K Yokoyama : Redox control in the pathophysiology of influenza virus infection. BMC Microbiol . 2020;20:214.
65. Kim HJ, Kim CH, Ryu JH, Kim MJ, Park CY, Lee JM, Holtzman MJ, Yoon JH: Reactive oxygen species induce antiviral innate immune response through IFN- lambda regulation in human nasal epithelial cells. Am J Respir Cell Mol Biol 2013; 49: 855-865.
66. Cuadrado A, Manda G, Hassan A, Alcaraz MJ, Barbas C, Daiber A, Ghezzi P, Leon R, Lopez MG, Oliva B, Pajares M, Rojo AI, Robledinos-Anton N, Valverde AM, Guney E, Schmidt HHHW: Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharmacol Rev 2018; 70: 348-383.
67. Yang CS, Kim JJ, Lee SJ, Hwang JH, Lee CH, Lee MS, Jo EK: TLR3-triggered reactive oxygen species contribute to inflammatory responses by activating signal transducer and activator of transcription-1. J Immunol 2013; 190: 6368-6377.
68. Wang MM, Lu M, Zhang CL, Wu X, Chen JX, Lv WW, Sun T, Qiu H, Huang SH: Oxidative stress modulates the expression of tolllike receptor 3 during respiratory syncytial virus infection in human lung epithelial A549 cells. Mol Med Rep 2018; 18: 1867-1877.
69. Vijayan V, Baumgart-Vogt E, Naidu S, Qian G, Immenschuh S: Bruton's tyrosine kinase is required for TLR-dependent heme oxygenase-1 gene activation via Nrf2 in macrophages. J Immunol 2011; 187: 817-827.
70. Zhang T, Ono K, Tsutsuki H, Ihara H, Islam W, Akaike T, Sawa T: Enhanced Cellular Polysulfides Negatively Regulate TLR4 Signaling and Mitigate Lethal Endotoxin Shock. Cell Chem Biol 2019; 26: 686-698 e684.
71. Ichikawa T, Sugiura H, Koarai A, Minakata Y, Kikuchi T, Morishita Y, Oka A, Kanai K, Kawabata H, Hiramatsu M, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Yamamoto N, Ichinose M: TLR3 activation augments matrix metalloproteinase production through reactive nitrogen species generation in human lung fibroblasts. J Immunol 2014; 192: 4977-4988.
72. Shishikura Y, Koarai A, Aizawa H, Yamaya M, Sugiura H, Watanabe M, Hashimoto Y, Numakura T, Makiguti T, Abe K, Yamada M, Kikuchi T, Hoshikawa Y, Okada Y, Ichinose M: Extracellular ATP is involved in dsRNA-induced MUC5AC production via P2Y2R in human airway epithelium. Respir Res 2016; 17: 121.
73. Kanai K, Koarai A, Shishikura Y, Sugiura H, Ichikawa T, Kikuchi T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M: Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells. Respir Investig 2015; 53: 137-148.
74. Karl G Nicholson , John M Wood, Maria Zambon: Influenza. Lancet 2003; 22: 1733- 45.
論文の公開元へ
